Genevieve Bergendahl

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma

Giselle L. Saulnier Sholler, Eugene W. Gerner, Genevieve Bergendahl et al. · PLoS ONE · 2015 · 139 citations · Full text

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Giselle L. Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl et al. · Scientific Reports · 2018 · 101 citations · Full text

A subset analysis of a phase <scp>II</scp> trial evaluating the use of <scp>DFMO</scp> as maintenance therapy for high‐risk neuroblastoma

Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson et al. · International Journal of Cancer · 2020 · 62 citations · Full text

High‐risk Neuroblastoma, Cancer Management, Dfmo Maintenance +17

Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons

Javier Oesterheld, William S. Ferguson, Jacqueline M. Kraveka et al. · Journal of Clinical Oncology · 2023 · 58 citations · Full text

A Phase 1 Study of Nifurtimox in Patients With Relapsed/Refractory Neuroblastoma

Giselle L. Saulnier Sholler, Genevieve Bergendahl, Laurent Brard et al. · Journal of Pediatric Hematology/Oncology · 2010 · 51 citations